Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05ZEW
|
||||
| Former ID |
DNCL003236
|
||||
| Drug Name |
INO-3510
|
||||
| Drug Type |
Vaccine
|
||||
| Indication | Influenza A virus H1N1; Influenza A virus H5N1 [ICD9: 487, 488; ICD10:J10, J11] | Phase 1 | [1] | ||
| Company |
Inovio Pharmaceuticals
|
||||
| Target and Pathway | |||||
| Target(s) | Human DNA | Target Info | [2] | ||
| References | |||||
| REF 1 | ClinicalTrials.gov (NCT01405885) A Study of DNA Vaccine With Electroporation for the Prevention of Disease Caused by H1 and H5 Influenza Virus. U.S. National Institutes of Health. | ||||
| REF 2 | Inovio Receives U.S. Patent for SynCon? H1N1 Influenza Universal Vaccine. Inovio. March 26, 2012. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.